Smaller infarctions and less inflammation has also been observed in mice subjected to myocardial ischemia-reperfusion and treated with TLR2 or TLR4 antagonists (anti-TLR2 antibody and Eritoran, respectively) [42,43]. This evidence concerns the gene TLR2 and myocardial ischemia.